Does Depakote (valproic acid) decrease blood pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Depakote Does Not Decrease Blood Pressure

Depakote (valproic acid) is not a blood pressure-lowering medication and is not indicated for hypertension treatment. According to the FDA drug label, Depakote's mechanism of action relates to increased brain concentrations of GABA for seizure control, with no established cardiovascular effects for blood pressure reduction 1.

Key Clinical Points

What Depakote Actually Does

  • Primary mechanism: Increases brain GABA concentrations for epilepsy treatment 1
  • No established BP-lowering mechanism: The drug label makes no mention of blood pressure reduction as a therapeutic effect 1
  • Not included in any hypertension guidelines: Multiple comprehensive hypertension guidelines (2024 ESC, 2025 AHA/ACC, 2007 Canadian, 2004 British) list first-line antihypertensive agents—ACE inhibitors, ARBs, calcium channel blockers, and diuretics—but Depakote is conspicuously absent from all recommendations 2, 3, 4

Important Safety Consideration: Hypotension Risk

Paradoxically, rapid IV infusion of valproate can cause hypotension as an adverse effect, not a therapeutic benefit. A case report documented a 75-year-old man who developed significant hypotension (nadir 82/44 mmHg) lasting 3 days after IV valproate loading, with a Naranjo probability score of 6 (probable causation) 5. Another study of rapid infusion (33-555 mg/min) reported two patients requiring vasopressors for hypotension 6.

Research Context (Not Clinical Practice)

While animal studies show valproate can affect blood pressure in experimental hypertension models 7, 8, 9, these findings:

  • Are limited to rat models with induced hypertension
  • Have not translated to human clinical use
  • Do not support using Depakote for blood pressure management

Clinical Bottom Line

If a patient on Depakote has hypertension, treat the hypertension with evidence-based antihypertensive medications (ACE inhibitors, ARBs, calcium channel blockers, or thiazide/thiazide-like diuretics per current guidelines 2). Do not rely on Depakote for blood pressure control.

Monitor for hypotension if administering IV valproate, particularly in elderly patients or those receiving rapid infusion rates 5, 6.

References

5
Research

Probable valproate sodium-associated hypotension.

The American journal of geriatric pharmacotherapy, 2010

9
Research

Infusion of Valproic Acid Into the Renal Medulla Activates Stem Cell Population and Attenuates Salt-Sensitive Hypertension in Dahl S Rats.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017

Related Questions

Can Depakote (valproic acid) cause hypotension and how should it be managed?
Does Depakote (valproic acid) cause hypertension?
How should Depakote (valproic acid) be managed in a patient taking antihypertensive medications, including considerations for drug interactions and monitoring?
What is the best allergy medication to use with Depakote (valproic acid)?
Can Depakote (valproic acid or divalproex) cause tardive dyskinesia?
In a patient with low serum iron, low transferrin saturation, and high ferritin indicating functional iron deficiency due to inflammation, what does an elevated haptoglobin signify and how should it be managed?
In a patient with de Quervain’s tenosynovitis who has a positive Finkelstein test, has completed an oral prednisone taper with nighttime splinting, a two‑week course of meloxicam (Mobic) with full‑time splinting, and a corticosteroid injection followed by two weeks of splint wear, and now reports pain recurrence after a single day without the brace and no aggravating activity, what are the next steps and when should the steroid therapy be considered failed?
What is the significance of a positive Immunoglobulin A (IgA) and complement component 3 (C3) reactivity on an antinuclear antibody (ANA) panel with a titre of 1:80?
In a patient on carvedilol (Coreg) 25 mg twice daily, lisinopril 20 mg daily, and amlodipine 10 mg daily, what is the next recommended step in hypertension management?
In a 79-year-old male with coronary artery disease and heart failure with preserved ejection fraction, diabetes mellitus, hypertension, trace bilateral peripheral edema, normal vital signs, normal ECG, and currently taking aspirin, atorvastatin (Lipitor), and metformin, who is scheduled for left hip replacement, what additional pre‑operative studies are indicated for clearance?
What should be done when a patient on testosterone replacement therapy has high free testosterone but normal total testosterone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.